Denmark
# |
Name |
Price to Book Ratio (P/B) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
28.72 |
Jan. 14, 2025 | USD 95.84 | 0.08% |
|
Denmark |
|
2 |
21.00 |
Jan. 14, 2025 | USD 91.43 | -1.85% |
|
Denmark |
|
3 |
15.07 |
Jan. 14, 2025 | USD 70.50 | 0.61% |
|
Denmark |
|
4 |
12.15 |
Jan. 14, 2025 | USD 54.16 | -1.39% |
|
Denmark |
|
5 |
9.86 |
Jan. 14, 2025 | USD 0.20 | -2.77% |
|
Denmark |
|
6 |
2.94 |
Jan. 14, 2025 | USD 216.88 | 1.28% |
|
Denmark |
|
7 |
1.60 |
Jan. 14, 2025 | USD 5.46 | 0.56% |
|
Denmark |
|
8 |
1.37 |
Jan. 14, 2025 | USD 26.62 | -0.36% |
|
Denmark |
|
9 |
0.90 |
Jan. 14, 2025 | USD 2.17 | 5.88% |
|
Denmark |
|
10 |
-29.87 |
Jan. 14, 2025 | USD 0.57 | 1.47% |
|
Denmark |
The Biotechnology company in Denmark with the highest Price to Book Ratio (P/B) is Zealand Pharma A/S (Copenhagen Stock Exchange: ZEAL.CO) at 28.72.
The Biotechnology company in Denmark with the lowest Price to Book Ratio (P/B) is Saniona AB (publ) (Stockholm Stock Exchange: SANION.ST) at -29.87.
The top 10 Biotechnology companies in Denmark by Price to Book Ratio (P/B) are Zealand Pharma A/S, Gubra A/S, ChemoMetec A/S, Novozymes A/S, BioPorto A/S, Genmab A/S, H. Lundbeck A/S, Bavarian Nordic A/S, ExpreS2ion Biotech Holding AB (publ) and Saniona AB (publ).
The bottom 10 Biotechnology companies in Denmark by Price to Book Ratio (P/B) are Saniona AB (publ), ExpreS2ion Biotech Holding AB (publ), Bavarian Nordic A/S, H. Lundbeck A/S, Genmab A/S, BioPorto A/S, Novozymes A/S, ChemoMetec A/S, Gubra A/S and Zealand Pharma A/S.